XWELL Net Profit Margin 2010-2025 | XWEL
XWELL net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| XWELL Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.03B | $-0.02B | -64.52% |
| 2024-12-31 | $0.03B | $-0.02B | -54.55% |
| 2024-09-30 | $0.03B | $-0.02B | -45.45% |
| 2024-06-30 | $0.03B | $-0.02B | -68.75% |
| 2024-03-31 | $0.03B | $-0.03B | -83.87% |
| 2023-12-31 | $0.03B | $-0.03B | -100.00% |
| 2023-09-30 | $0.03B | $-0.04B | -123.33% |
| 2023-06-30 | $0.03B | $-0.03B | -94.12% |
| 2023-03-31 | $0.04B | $-0.03B | -85.00% |
| 2022-12-31 | $0.06B | $-0.03B | -56.14% |
| 2022-09-30 | $0.08B | $-0.02B | -20.51% |
| 2022-06-30 | $0.09B | $0.00B | -3.19% |
| 2022-03-31 | $0.09B | $0.00B | 1.12% |
| 2021-12-31 | $0.07B | $0.00B | 5.41% |
| 2021-09-30 | $0.05B | $-0.01B | -31.11% |
| 2021-06-30 | $0.02B | $-0.03B | -144.44% |
| 2021-03-31 | $0.01B | $-0.08B | -900.00% |
| 2020-12-31 | $0.01B | $-0.09B | -1137.50% |
| 2020-09-30 | $0.02B | $-0.08B | -436.84% |
| 2020-06-30 | $0.03B | $-0.08B | -256.25% |
| 2020-03-31 | $0.05B | $-0.03B | -64.44% |
| 2019-12-31 | $0.05B | $-0.02B | -42.86% |
| 2019-09-30 | $0.05B | $-0.02B | -42.00% |
| 2019-06-30 | $0.05B | $-0.02B | -38.00% |
| 2019-03-31 | $0.05B | $-0.02B | -34.00% |
| 2018-12-31 | $0.05B | $-0.04B | -74.51% |
| 2018-09-30 | $0.05B | $-0.04B | -82.35% |
| 2018-06-30 | $0.05B | $-0.04B | -86.27% |
| 2018-03-31 | $0.05B | $-0.05B | -92.16% |
| 2017-12-31 | $0.05B | $-0.03B | -59.18% |
| 2017-09-30 | $0.03B | $-0.02B | -68.75% |
| 2017-06-30 | $0.02B | $-0.02B | -100.00% |
| 2017-03-31 | $0.02B | $-0.03B | -130.00% |
| 2016-12-31 | $0.01B | $-0.02B | -218.18% |
| 2016-09-30 | $0.04B | $0.00B | -10.26% |
| 2015-12-31 | $0.02B | $-0.01B | -52.17% |
| 2015-03-31 | $0.00B | $-0.11B | -10500.00% |
| 2014-12-31 | $0.00B | $-0.11B | -10900.00% |
| 2014-03-31 | $0.00B | $-0.05B | -5200.00% |
| 2013-06-30 | $0.00B | $-0.04B | -4000.00% |
| 2011-06-30 | $0.00B | $-0.01B | 0.00% |
| 2011-03-31 | $0.00B | $-0.01B | 0.00% |
| 2010-12-31 | $0.00B | $-0.01B | 0.00% |
| 2010-06-30 | $0.00B | $-0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.869B | 26.80 |
| CVS Health (CVS) | United States | $84.351B | 10.48 |
| Elevance Health (ELV) | United States | $78.372B | 10.11 |
| Cencora (COR) | United States | $58.632B | 20.40 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $21.669B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.584B | 17.51 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.511B | 0.00 |
| Solventum (SOLV) | United States | $13.191B | 13.96 |
| CochLear (CHEOY) | Australia | $12.755B | 0.00 |
| ICON (ICLR) | Ireland | $11.919B | 11.08 |
| Revvity (RVTY) | United States | $11.635B | 20.02 |
| Viatris (VTRS) | United States | $10.798B | 3.71 |
| Avantor (AVTR) | United States | $9.206B | 13.38 |
| Medpace Holdings (MEDP) | United States | $9.166B | 24.34 |
| HealthEquity (HQY) | United States | $8.806B | 38.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.474B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.559B | 14.81 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.749B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.885B | 28.77 |
| BrightSpring Health Services (BTSG) | United States | $3.868B | 35.48 |
| Sotera Health (SHC) | United States | $3.236B | 18.39 |
| Surgery Partners (SGRY) | United States | $2.823B | 36.72 |
| Concentras Parent (CON) | United States | $2.608B | 15.07 |
| Alignment Healthcare (ALHC) | United States | $2.600B | 0.00 |
| Organon (OGN) | United States | $2.527B | 2.69 |
| GeneDx Holdings (WGS) | United States | $2.446B | 94.22 |
| Ardent Health (ARDT) | United States | $1.902B | 8.11 |
| PACS (PACS) | United States | $1.902B | 0.00 |
| Progyny (PGNY) | United States | $1.839B | 40.47 |
| Premier (PINC) | United States | $1.812B | 13.75 |
| GoodRx Holdings (GDRX) | United States | $1.693B | 33.86 |
| Teladoc Health (TDOC) | United States | $1.416B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.155B | 8.79 |
| CareDx (CDNA) | United States | $1.027B | 16.04 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.965B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.813B | 7.61 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.698B | 10.57 |
| Embecta (EMBC) | United States | $0.586B | 3.95 |
| InnovAge Holding (INNV) | United States | $0.563B | 0.00 |
| LifeMD (LFMD) | United States | $0.554B | 0.00 |
| Omada Health (OMDA) | $0.481B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.467B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| So-Young (SY) | China | $0.436B | 0.00 |
| Enhabit (EHAB) | United States | $0.371B | 30.50 |
| Performant Healthcare (PHLT) | United States | $0.329B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.310B | 0.00 |
| Beauty Health (SKIN) | United States | $0.277B | 0.00 |
| Oncology Institute (TOI) | United States | $0.228B | 0.00 |
| DocGo (DCGO) | United States | $0.155B | 25.33 |
| Pheton Holdings (PTHL) | China | $0.129B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.091B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| OpGen (OPGN) | United States | $0.051B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |